These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 35761406)
1. Empirical treatment against cytomegalovirus and tuberculosis in HIV-infected infants with severe pneumonia: study protocol for a multicenter, open-label randomized controlled clinical trial. Rojo P; Moraleda C; Tagarro A; Domínguez-Rodríguez S; Castillo LM; Tato LMP; López AS; Manukyan L; Marcy O; Leroy V; Nardone A; Burger D; Bassat Q; Bates M; Moh R; Iroh Tam PY; Mvalo T; Magallhaes J; Buck WC; Sacarlal J; Musiime V; Chabala C; Mujuru HA Trials; 2022 Jun; 23(1):531. PubMed ID: 35761406 [TBL] [Abstract][Full Text] [Related]
2. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial. Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543 [TBL] [Abstract][Full Text] [Related]
3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
4. Pneumocystis carinii and cytomegalovirus infections in severely ill, HIV-infected African infants. Jeena PM; Coovadia HM; Chrystal V Ann Trop Paediatr; 1996 Dec; 16(4):361-8. PubMed ID: 8985536 [TBL] [Abstract][Full Text] [Related]
5. Rapid urine-based screening for tuberculosis to reduce AIDS-related mortality in hospitalized patients in Africa (the STAMP trial): study protocol for a randomised controlled trial. Gupta-Wright A; Fielding KL; van Oosterhout JJ; Wilson DK; Corbett EL; Flach C; Reddy KP; Walensky RP; Peters JA; Alufandika-Moyo M; Lawn SD BMC Infect Dis; 2016 Sep; 16(1):501. PubMed ID: 27659507 [TBL] [Abstract][Full Text] [Related]
7. Intensified tuberculosis treatment to reduce the mortality of HIV-infected and uninfected patients with tuberculosis meningitis (INTENSE-TBM): study protocol for a phase III randomized controlled trial. Maitre T; Bonnet M; Calmy A; Raberahona M; Rakotoarivelo RA; Rakotosamimanana N; Ambrosioni J; Miró JM; Debeaudrap P; Muzoora C; Davis A; Meintjes G; Wasserman S; Wilkinson R; Eholié S; Nogbou FE; Calvo-Cortes MC; Chazallon C; Machault V; Anglaret X; Bonnet F Trials; 2022 Nov; 23(1):928. PubMed ID: 36348453 [TBL] [Abstract][Full Text] [Related]
8. Shorter treatment for minimal tuberculosis (TB) in children (SHINE): a study protocol for a randomised controlled trial. Chabala C; Turkova A; Thomason MJ; Wobudeya E; Hissar S; Mave V; van der Zalm M; Palmer M; Kapasa M; Bhavani PK; Balaji S; Raichur PA; Demers AM; Hoddinott G; Owen-Powell E; Kinikar A; Musoke P; Mulenga V; Aarnoutse R; McIlleron H; Hesseling A; Crook AM; Cotton M; Gibb DM; Trials; 2018 Apr; 19(1):237. PubMed ID: 29673395 [TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of valganciclovir in patients with symptomatic congenital cytomegalovirus disease: Study Protocol Clinical Trial (SPIRIT Compliant). Morioka I; Kakei Y; Omori T; Nozu K; Fujioka K; Yoshikawa T; Moriuchi H; Ito Y; Oka A Medicine (Baltimore); 2020 Apr; 99(17):e19765. PubMed ID: 32332615 [TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy assessment of allogeneic human dental pulp stem cells to treat patients with severe COVID-19: structured summary of a study protocol for a randomized controlled trial (Phase I / II). Ye Q; Wang H; Xia X; Zhou C; Liu Z; Xia ZE; Zhang Z; Zhao Y; Yehenala J; Wang S; Zhou G; Hu K; Wu B; Wu CT; Wang S; He Y Trials; 2020 Jun; 21(1):520. PubMed ID: 32532356 [TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of nelfinavir in asymptomatic and mild COVID-19 patients: a structured summary of a study protocol for a multicenter, randomized controlled trial. Hosogaya N; Miyazaki T; Fukushige Y; Takemori S; Morimoto S; Yamamoto H; Hori M; Kurokawa T; Kawasaki Y; Hanawa M; Fujii Y; Hanaoka H; Iwami S; Watashi K; Yamagoe S; Miyazaki Y; Wakita T; Izumikawa K; Yanagihara K; Mukae H; Kohno S; Trials; 2021 Apr; 22(1):309. PubMed ID: 33910617 [TBL] [Abstract][Full Text] [Related]
12. Expanding Xpert MTB/RIF Ultra® and LF-LAM testing for diagnosis of tuberculosis among HIV-positive adults admitted to hospitals in Tanzania and Mozambique: a randomized controlled trial (the EXULTANT trial). Mangu C; Cossa M; Ndege R; Khosa C; Leukes V; de la Torre-Pérez L; Machiana A; Kivuma B; Mnzava D; Zachariah C; Manjate P; Tagliani E; Schacht C; Buech J; Singh S; Ehrlich J; Riess F; Sanz S; Kranzer K; Cox H; Sabi I; Nguenha D; Meggi B; Weisser M; Ntinginya N; Schumacher S; Ruhwald M; Penn-Nicholson A; Garcia-Basteiro AL; BMC Infect Dis; 2024 Aug; 24(1):831. PubMed ID: 39148008 [TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics, SAfety/tolerability, and EFficacy of high-dose RIFampicin in tuberculosis-HIV co-infected patients on efavirenz- or dolutegravir-based antiretroviral therapy: study protocol for an open-label, phase II clinical trial (SAEFRIF). Nabisere R; Musaazi J; Denti P; Aber F; Lamorde M; Dooley KE; Aarnoutse R; Sloan DJ; Sekaggya-Wiltshire C Trials; 2020 Feb; 21(1):181. PubMed ID: 32054536 [TBL] [Abstract][Full Text] [Related]
14. A Phase I/II Clinical Trial to evaluate the efficacy of baricitinib to prevent respiratory insufficiency progression in onco-hematological patients affected with COVID19: A structured summary of a study protocol for a randomised controlled trial. Moreno-González G; Mussetti A; Albasanz-Puig A; Salvador I; Sureda A; Gudiol C; Salazar R; Marin M; Garcia M; Navarro V; de la Haba Vaca I; Coma E; Sanz-Linares G; Dura X; Fontanals S; Serrano G; Cruz C; Mañez R Trials; 2021 Feb; 22(1):116. PubMed ID: 33546739 [TBL] [Abstract][Full Text] [Related]
15. Impact of systematic early tuberculosis detection using Xpert MTB/RIF Ultra in children with severe pneumonia in high tuberculosis burden countries (TB-Speed pneumonia): a stepped wedge cluster randomized trial. Vessière A; Font H; Gabillard D; Adonis-Koffi L; Borand L; Chabala C; Khosa C; Mavale S; Moh R; Mulenga V; Mwanga-Amumpere J; Taguebue JV; Eang MT; Delacourt C; Seddon JA; Lounnas M; Godreuil S; Wobudeya E; Bonnet M; Marcy O BMC Pediatr; 2021 Mar; 21(1):136. PubMed ID: 33743621 [TBL] [Abstract][Full Text] [Related]
16. Cytomegalovirus viraemia in HIV exposed and infected infants: prevalence and clinical utility for diagnosing CMV pneumonia. Hsiao NY; Zampoli M; Morrow B; Zar HJ; Hardie D J Clin Virol; 2013 Sep; 58(1):74-8. PubMed ID: 23727304 [TBL] [Abstract][Full Text] [Related]
17. Cytomegalovirus infection in HIV-infected versus non-infected infants and HIV disease progression in Cytomegalovirus infected versus non infected infants early treated with cART in the ANRS 12140-Pediacam study in Cameroon. Kfutwah AK; Ngoupo PA; Sofeu CL; Ndongo FA; Guemkam G; Ndiang ST; Owona F; Penda IC; Tchendjou P; Rouzioux C; Warszawski J; Faye A; Tejiokem MC BMC Infect Dis; 2017 Mar; 17(1):224. PubMed ID: 28335737 [TBL] [Abstract][Full Text] [Related]
18. Recombinant human C1 esterase inhibitor (conestat alfa) in the prevention of severe SARS-CoV-2 infection in hospitalized patients with COVID-19: A structured summary of a study protocol for a randomized, parallel-group, open-label, multi-center pilot trial (PROTECT-COVID-19). Urwyler P; Charitos P; Moser S; Heijnen IAFM; Trendelenburg M; Thoma R; Sumer J; Camacho-Ortiz A; Bacci MR; Huber LC; Stüssi-Helbling M; Albrich WC; Sendi P; Osthoff M Trials; 2021 Jan; 22(1):1. PubMed ID: 33397449 [TBL] [Abstract][Full Text] [Related]
19. Sarilumab versus standard of care for the early treatment of COVID-19 pneumonia in hospitalized patients: SARTRE: a structured summary of a study protocol for a randomised controlled trial. Caballero Bermejo AF; Ruiz-Antorán B; Fernández Cruz A; Diago Sempere E; Callejas Díaz A; Múñez Rubio E; Avendaño-Solá C; Ramos Martínez A; Sancho López A; Trials; 2020 Sep; 21(1):794. PubMed ID: 32938496 [TBL] [Abstract][Full Text] [Related]
20. A Phase 3 Open-label, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Intravenously Administered Ravulizumab Compared with Best Supportive Care in Patients with COVID-19 Severe Pneumonia, Acute Lung Injury, or Acute Respiratory Distress Syndrome: A structured summary of a study protocol for a randomised controlled trial. Smith K; Pace A; Ortiz S; Kazani S; Rottinghaus S Trials; 2020 Jul; 21(1):639. PubMed ID: 32660611 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]